A detailed history of Goldman Sachs Group Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 14,826,526 shares of MRK stock, worth $1.45 Billion. This represents 0.28% of its overall portfolio holdings.

Number of Shares
14,826,526
Previous 12,532,975 18.3%
Holding current value
$1.45 Billion
Previous $1.55 Billion 8.52%
% of portfolio
0.28%
Previous 0.27%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $255 Million - $296 Million
2,293,551 Added 18.3%
14,826,526 $1.68 Billion
Q2 2024

Aug 13, 2024

BUY
$123.8 - $132.96 $109 Million - $117 Million
876,795 Added 7.52%
12,532,975 $1.55 Billion
Q1 2024

May 15, 2024

SELL
$113.24 - $131.95 $51 Million - $59.4 Million
-450,043 Reduced 3.72%
11,656,180 $1.54 Billion
Q4 2023

Feb 13, 2024

SELL
$100.18 - $109.02 $91.6 Million - $99.7 Million
-914,714 Reduced 7.02%
12,106,223 $1.32 Billion
Q3 2023

May 14, 2024

BUY
$102.95 - $114.33 $94.2 Million - $105 Million
914,714 Added 7.56%
13,020,937 $1.34 Billion
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $47.1 Million - $52.3 Million
457,054 Added 3.64%
13,020,937 $1.34 Billion
Q2 2023

May 14, 2024

SELL
$108.61 - $118.38 $116 Million - $127 Million
-1,071,957 Reduced 7.86%
12,563,883 $1.45 Billion
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $116 Million - $127 Million
-1,071,957 Reduced 7.86%
12,563,883 $1.45 Billion
Q1 2023

May 14, 2024

BUY
$102.94 - $114.86 $143 Million - $160 Million
1,389,705 Added 11.35%
13,635,840 $1.45 Billion
Q1 2023

May 11, 2023

BUY
$102.94 - $114.86 $143 Million - $160 Million
1,389,705 Added 11.35%
13,635,840 $1.45 Billion
Q4 2022

May 14, 2024

BUY
$87.44 - $112.11 $12.5 Million - $16 Million
142,535 Added 1.18%
12,246,135 $1.36 Billion
Q4 2022

Feb 13, 2023

BUY
$87.44 - $112.11 $12.5 Million - $16 Million
142,535 Added 1.18%
12,246,135 $1.36 Billion
Q3 2022

May 14, 2024

SELL
$84.53 - $94.96 $81.2 Million - $91.2 Million
-960,511 Reduced 7.35%
12,103,600 $1.04 Billion
Q3 2022

Nov 10, 2022

SELL
$84.53 - $94.96 $81.2 Million - $91.2 Million
-960,511 Reduced 7.35%
12,103,600 $1.04 Billion
Q2 2022

May 14, 2024

BUY
$83.49 - $94.64 $80 Million - $90.7 Million
957,888 Added 7.91%
13,064,111 $1.19 Billion
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $204 Million - $231 Million
2,444,607 Added 23.02%
13,064,111 $1.19 Billion
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $210 Million - $236 Million
2,860,675 Added 36.87%
10,619,504 $871 Million
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $201 Million - $252 Million
-2,779,545 Reduced 26.38%
7,758,829 $595 Million
Q3 2021

Nov 10, 2021

BUY
$71.68 - $78.83 $755 Million - $831 Million
10,538,374 New
10,538,374 $792 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.